Potential of Serum ApoC1 as a Noninvasive Biomarker for Breast Cancer Detection and Prognosis: A Prospective Case–Control Study

Breast cancer (BC) is one of the most frequent malignancies. Apolipoprotein C1 (ApoC1) has been known as a promising therapeutic target and valuable prognostic and diagnostic biomarker in cancers. The aim of this study was to explore the diagnostic implication of serum ApoC1 concentration in new cases of BC.

• Publication year

  2025

• Venue

  Cancer Reports

• Publication date

  2025-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cnr2.70359PMID 41071085PMCID 12512904
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life

  2023cited by this paper
• Upregulation of APOC1 Promotes Colorectal Cancer Progression and Serves as a Potential Therapeutic Target Based on Bioinformatics Analysis

  2023cited by this paper
• Apolipoproteins: New players in cancers

  2022cited by this paper
• Apolipoprotein C1 (APOC1), A Candidate Diagnostic Serum Biomarker for Breast Cancer Identified by Serum Proteomics Study.

  2022cited by this paper
• Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review

  2022influential reference
• Elevation of effective p53 expression sensitizes wild-type p53 breast cancer cells to CDK7 inhibitor THZ1

  2022cited by this paper
• A Review of Biosensors for Detecting Tumor Markers in Breast Cancer

  2022cited by this paper
• Apolipoproteins in vascular biology and atherosclerotic disease

  2021cited by this paper
• The Apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway.

  2021cited by this paper
• Apolipoprotein C‐II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway

  2021cited by this paper
• Current and future applications of biomarkers in samples collected through minimally invasive methods for cancer medicine and population‐based research

  2021cited by this paper
• Apolipoprotein Mimetics in Cancer.

  2020cited by this paper
• Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma

  2020cited by this paper
• A review on methods for diagnosis of breast cancer cells and tissues

  2020cited by this paper
• Apolipoprotein: prospective biomarkers in digestive tract cancer

  2020cited by this paper
• ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3

  2020cited by this paper
• Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond

  2019cited by this paper
• Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer.

  2019cited by this paper
• Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer

  2019cited by this paper
• Identification a novel clinical biomarker in early diagnosis of human non-small cell lung cancer

  2019cited by this paper
• Apolipoproteins and cancer

  2019cited by this paper
• Epidemiology and Histopathology of Breast Cancer in Iran versus Other Middle Eastern Countries

  2018cited by this paper
• ANP32A regulates histone H3 acetylation and promotes leukemogenesis

  2018cited by this paper
• The new TNM-based staging of breast cancer

  2018cited by this paper
• Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro

  2018cited by this paper
• Early Diagnosis of Breast Cancer

  2017cited by this paper
• Revisiting biomarker discovery by plasma proteomics

  2017cited by this paper
• Apolipoprotein C‐I plays a role in the pathogenesis of glomerulosclerosis

  2017cited by this paper
• Identification of Apolipoprotein C-I Peptides as a Potential Biomarker and its Biological Roles in Breast Cancer

  2016cited by this paper
• Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes

  2016cited by this paper
• Diagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometry

  2016cited by this paper
• [Early detection of breast cancer and the interpretation of results of survival studies].

  2015cited by this paper
• Effectiveness of population‐based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: Socioeconomic status, parity, and age at birth of first child

  2015cited by this paper
• Breast Cancer Detection Using Two-Step Reduction of Features Extracted From Fine Needle Aspirate and Data Mining Algorithms

  2015cited by this paper
• Breast MRI, digital mammography and breast tomosynthesis: comparison of three methods for early detection of breast cancer.

  2015cited by this paper
• Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trial

  2014cited by this paper
• Normalization of Shapiro-Wilk test with known mean

  2014influential reference
• Association Analysis of Dyslipidemia-Related Genes in Diabetic Nephropathy

  2013cited by this paper
• Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays

  2012cited by this paper
• Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood.

  2012cited by this paper
• Review of Electromagnetic Techniques for Breast Cancer Detection

  2011cited by this paper
• Identification of novel serum biomarkers in child nephroblastoma using proteomics technology

  2010cited by this paper
• Detection and identification of potential biomarkers of breast cancer

  2010cited by this paper
• Clinical relevance of HER2 overexpression/amplification in patients with small tumor size and node-negative breast cancer.

  2009cited by this paper
• Detection and Identification of Potential Biomarkers of Non-small Cell Lung Cancer

  2009cited by this paper
• High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.

  2009cited by this paper
• Discovery and identification of potential biomarkers of papillary thyroid carcinoma

  2009cited by this paper
• Detection of Colorectal Cancer by Serum and Tissue Protein Profiling: A Prospective Study in a Population at Risk

  2008cited by this paper
• Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer.

  2008cited by this paper
• Apolipoprotein C-1 maintains cell survival by preventing from apoptosis in pancreatic cancer cells

  2008cited by this paper
• Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers.

  2008cited by this paper
• Cathepsin B, Cathepsin H, Cathepsin X and Cystatin C in Sera of Patients with Early-Stage and Inflammatory Breast Cancer

  2008cited by this paper
• Genetic association of an apolipoprotein C-I (APOC1) gene polymorphism with late-onset Alzheimer's disease.

  2002cited by this paper
• Testing Homogeneity of Variances

  1966cited by this paper

• Endoplazmik retikuluma lokalize edilen TurboID aracılı işaretleme ile MCF-10A ve MDA-MB-231 hücrelerine ait sekretom profillerinin belirlenmesi

  2026cites this paper